Skip to main content

Magnetic Resonance Imaging of Brain Tumors Using Iron Oxide Nanoparticles

  • Chapter
  • First Online:
Methods of Cancer Diagnosis, Therapy, and Prognosis

Part of the book series: Methods of Cancer Diagnosis, Therapy and Prognosis ((HAYAT,volume 8))

  • 1198 Accesses

Abstract

Iron oxide nanoparticles ­provide an alternative to gadolinium based contrast agents for use in magnetic resonance imaging of brain tumors. These nanoparticles have different biologic and imaging properties that provide complementary information about inflammation and subtle defects in the blood-brain barrier that are not seen with gadolinium as well as repeated serial imaging without the readministration of contrast agents. These particles can also be used with dynamic magnetic resonance imaging to measure perfusion properties of brain tumors without the confounding effects of blood brain barrier permeability on the measurements. Cellular labeling using iron oxide nanoparticles may allow for imaging of cellular trafficking in the brain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

REFERENCES

  • Arbab, A.S., Yocum, G.T., Kalish, H., Jordan, E.K., Anderson, S.A., Khakoo, A.Y., Read, E.J., and Frank, J.A. (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217–1223

    Article  PubMed  CAS  Google Scholar 

  • Arbab, A.S., Rad, A.M., Iskander, A.S., Jafari-Khouzani, K., Brown, S.L., Churchman, J.L., Ding, G., Jiang, Q., Frank, J.A., Soltanian-Zadeh, H., and Peck, D.J. (2007) Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study. Magn. Reson. Med. 58:519–526

    Article  PubMed  Google Scholar 

  • Bremer, C., Mustafa, M., Bogdanov, A., Jr., Ntziachristos, V., Petrovsky, A., and Weissleder, R. (2003) Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology 226:214–220

    Article  PubMed  Google Scholar 

  • Cao, Y., Tsien, C.I., Nagesh, V., Junck, L., Ten Haken, R., Ross, B.D., Chenevert, T.L., and Lawrence, T.S. (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. Int. J. Radiat. Oncol. Biol. Phys. 64:876–885

    Article  PubMed  Google Scholar 

  • Denis, M.C., Mahmood, U., Benoist, C., Mathis, D., and Weissleder, R. (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc. Natl. Acad. Sci. USA 101:12634–12639

    Article  PubMed  CAS  Google Scholar 

  • Enochs, W.S., Harsh, G., Hochberg, F., and Weissleder, R. (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9:228–232

    Article  PubMed  CAS  Google Scholar 

  • Harisinghani, M.G., Barentsz, J., Hahn, P.F., Deserno, W.M., Tabatabaei, S., van de Kaa, C.H., de la Rosette, J., and Weissleder, R. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348:2491–2499

    Article  PubMed  Google Scholar 

  • Hunt, M.A., Bago, A.G., and Neuwelt, E.A. (2005) Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. AJNR Am. J. Neuroradiol. 26:1084–1088

    PubMed  Google Scholar 

  • Jaffer, F.A., and Weissleder, R. (2005) Molecular imaging in the clinical arena. JAMA 293:855–862

    Article  PubMed  CAS  Google Scholar 

  • Jung, C.W., and Jacobs, P. (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13:661–674

    Article  PubMed  CAS  Google Scholar 

  • Keller, T.M., Michel, S.C.A., Frohlich, J., Fink, D., Caduff, R., Marincek, B., and Kubik-Huch, R.A. (2004) USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur. Radiol. 14:937–944

    Article  PubMed  Google Scholar 

  • Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R., and Josephson, L. (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63:8122–8125

    PubMed  CAS  Google Scholar 

  • Knauth, M., Aras, N., Wirtz, C.R., Dorfler, A., Engelhorn, T., and Sartor, K. (1999) Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am. J. Neuroradiol. 20:1547–1553

    PubMed  CAS  Google Scholar 

  • Knauth, M., Egelhof, T., Roth, S.U., Wirtz, C.R., and Sartor, K. (2001a) Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am. J. Neuroradiol. 22:99–102

    PubMed  CAS  Google Scholar 

  • Knauth, M., Wirtz, C.R., Aras, N., and Sartor, K. (2001b) Low-field interventional MRI in neurosurgery: finding the right dose of contrast medium. Neuroradiology 43:254–258

    Article  PubMed  CAS  Google Scholar 

  • Landry, R., Jacobs, P.M., Davis, R., Shenouda, M., and Bolton, W.K. (2005) Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am. J. Nephrol. 25:400–410

    Article  PubMed  CAS  Google Scholar 

  • Moore, A., Marecos, E., Bogdanov, A., Jr., and Weissleder, R. (2000) Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–574

    PubMed  CAS  Google Scholar 

  • Muldoon, L.L., Sandor, M., Pinkston, K.E., and Neuwelt, E.A. (2005) Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57:785–796

    Article  PubMed  Google Scholar 

  • Murillo, T.P., Sandquist, C., Jacobs, P.M., Nesbit, G., Manninger, S., and Neuwelt, E.A. (2005) Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent. Therapy 2:871–882

    Article  CAS  Google Scholar 

  • Neuwelt, E.A., Weissleder, R., Nilaver, G., Kroll, R.A., Roman-Goldstein, S., Szumowski, J., Pagel, M.A., Jones, R. S., Remsen, L.G., McCormick, C.I., Shannon, E.M., and Muldoon, L.L. (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34:777–784

    Article  PubMed  CAS  Google Scholar 

  • Neuwelt, E.A., Varallyay, P., Bago, A.G., Muldoon, L.L., Nesbit, G., and Nixon, R. (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol. Appl. Neurobiol. 30:456–471

    Article  PubMed  CAS  Google Scholar 

  • Neuwelt, E.A., Varallyay, C.G., Manninger, S., Solymosi, D., Haluska, M., Hunt, M.A., Nesbit, G., Stevens, A., Jerosch-Herold, M., Jacobs, P.M., and Hoffman, J.M. (2007) The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 60:601–611; discussion 611–602

    Article  PubMed  Google Scholar 

  • Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., and Corot, C. (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39:56–63

    Article  PubMed  CAS  Google Scholar 

  • Remsen, L.G., McCormick, C.I., Roman-Goldstein, S., Nilaver, G., Weissleder, R., Bogdanov, A., Hellstrom, I., Kroll, R.A., and Neuwelt, E.A. (1996) MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am. J. Neuroradiol. 17:411–418

    PubMed  CAS  Google Scholar 

  • Taschner, C.A., Wetzel, S.G., Tolnay, M., Froehlich, J., Merlo, A., and Radue, E.W. (2005) Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR Am. J. Roentgenol. 185:1477–1486

    Article  PubMed  Google Scholar 

  • Varallyay, P., Nesbit, G., Muldoon, L.L., Nixon, R.R., Delashaw, J., Cohen, J.I., Petrillo, A., Rink, D., and Neuwelt, E.A. (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am. J. Neuroradiol. 23:510–519

    PubMed  Google Scholar 

  • Wirtz, C.R., Knauth, M., Staubert, A., Bonsanto, M.M., Sartor, K., Kunze, S., and Tronnier, V.M. (2000) Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46:1112–1120; discussion 1120–1112

    Article  PubMed  CAS  Google Scholar 

  • Zimmer, C., Wright, S.C., Jr., Engelhardt, R.T., Johnson, G.A., Kramm, C., Breakefield, X.O., and Weissleder, R. (1997) Tumor cell endocytosis imaging facilitates delineation of the glioma–brain interface. Exp. Neurol. 143:61–69

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew A. Hunt .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Netherlands

About this chapter

Cite this chapter

Hunt, M.A., Neuwelt, E.A. (2011). Magnetic Resonance Imaging of Brain Tumors Using Iron Oxide Nanoparticles. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-90-481-8665-5_23

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-8664-8

  • Online ISBN: 978-90-481-8665-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics